Probiotics for newly diagnosed IBD
Part of Digestive system clinical trials.
This study tests whether taking probiotics can help prevent or treat inflammatory bowel disease (IBD) in people recently diagnosed. It aims to see if friendly bacteria can calm gut inflammation and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with IBD (Crohn's disease or ulcerative colitis) for at least 3 months, but less than 3 years.
- You do not have other serious health conditions like autoimmune diseases, infections, or cancer.
- You have not used antibiotics, probiotics, or prebiotics in the past 3 months.
- You have not had cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies treatment approaches for inflammatory bowel disease (IBD) in people who are newly diagnosed. It may help researchers find better care by learning how well the study treatment works early in the disease.
This study tests whether a multi-strain probiotic supplement can change the gut bacteria in children and teens with inflammatory bowel disease (IBD). Researchers will collect stool samples to see if the probiotics help restore healthy gut bacteria and potentially improve symptoms.
This study tests whether a daily probiotic supplement (a beneficial bacteria) can improve the protective lining of the gut and reduce leakage in people with inflammatory bowel disease (IBD). It involves taking the supplement for a period of time and undergoing some measurements of gut health.
This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.
This trial tests whether adding Probiotic 6600 to your usual treatment can help manage colitis, including ulcerative colitis or Crohn's disease. It aims to see if the probiotic improves symptoms and is safe to use.
This study is testing whether adding a probiotic (Bacillus subtilis) to standard infliximab treatment can improve outcomes for people with active Crohn's disease. It aims to see if the probiotic helps the medication work better.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.